Trademark Overview
On Thursday, May 29, 2025, a trademark application was filed for EXCELLERGY with the United States Patent and Trademark Office. The USPTO has given the EXCELLERGY trademark a serial number of 99208934. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 29, 2025. This trademark is owned by Excellergy, Inc.. The EXCELLERGY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; chemical and biological diagnostic preparations and substances for clinical and medical laboratory use in drug discovery and nucleic acid and protein therapeutics
Providing medical information and patient support services, namely, pharmaceutical advice and consultation in the nature of providing online information regarding pharmaceuticals and the treatment and prevention of various illnesses, disorders and maladies; providing health and medical information about pharmaceuticals; information services, namely, providing medical information to patients; providing medical consultancy and advisory services via a global computer network in the fields of pharmaceuticals and various illnesses, disorders and maladies
Biotechnology, medical and scientific research, and development services in the field of protein therapeutics and diagnostics; biotechnology research services, namely, protein therapeutics development for applications in the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; biotechnology research services, namely, protein therapeutics development for applications in the treatment of allergies, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; medical, pharmaceutical and scientific research and development services in the field of protein therapeutics and diagnostics
